Describing the development of our lead asset SQ3370, from preclinical work through our Phase 1 clinical trial.
This is the first example of click chemistry being used inside the human body. We have demonstrated that we are able to selectively use and control chemistry inside the human body, a process that is truly bioorthogonal to all other cellular processes.
